openPR Logo
Press release

Choroidal Neovascularization Market to Significant Growth Foreseen by 2017 - 2025

Choroidal Neovascularization Market to Significant Growth

Choroidal neovascularization is a disease that results in the formation of new blood vessels in the brunch membrane of choroid layer of eye. It occurs due to the secretion of excess amount of vascular endothelial growth factor. It can also occur, when a patient suffers with wet macular degeneration. Also, choroidal neovascularization can be caused due to genetic diseases such as optic disc drusen and pseudoxanthoma elasticum. It is also associated with myopia (at extreme stage) and malignant myopic degeneration. The primary symptoms of the disease are deterioration of central vision, color disturbances, metamorphopsia, apparent change in image size and paracentral or central scotoma. Choroidal neovascularization can be classified as extrafoveal, juxtafoveal and subfoveal, based on their location from the center of fovea.

A sample of this report is available upon request @  https://www.persistencemarketresearch.com/samples/3712

The disease is diagnosed through fluorescein angiography, indocyanine green angiography and optical coherence tomography. The disease is treated through anti-VEGF therapy, photodynamic therapy and corticosteroids. Currently the adoption rate for anti-VEGF therapy is high followed by photodynamic therapy. Drugs that are advised during anti-VEGF therapy include Avastin, Macugen and Lucentis. Visudyne, a photosensitive drug is given to the patients who are undergoing photodynamic therapy. Other treatment methods include laser photocoagulation, surgical excision of subfoveal choroidal neovascularization, surgical translocation of the fovea, and low-dose radiation therapy.

Rise in geriatric population will drive the growth of this market. This is due to the fact that the occurrence of disease increases with age, and hence will increase the demand for diagnostics and treatment of the disease. Also, increasing initiatives for R&D for the drugs treating choroidal neovascularization by various companies will also propel the growth of the market. The major players operating in the choroidal neovascularization market include Affitech A/S, F. Hoffmann-La Roche Ltd., Lpath, Inc., Mat Biopharma, Promedior, Inc., Regeneron Pharmaceuticals, Inc., Resolvyx Pharmaceuticals, Inc and Sanwa Kagaku Kenkyusho Co., Ltd among other significant players.

To view TOC of this report is available upon request @ https://www.persistencemarketresearch.com/toc/3712

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
Telephone - +1-646-568-7751
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Choroidal Neovascularization Market to Significant Growth Foreseen by 2017 - 2025 here

News-ID: 1266277 • Views:

More Releases from Persistence Market Research

U.S. Internet of Things (IoT) Market to Reach $609.2 Billion by 2032, Driven by 20.1% CAGR Growth
U.S. Internet of Things (IoT) Market to Reach $609.2 Billion by 2032, Driven by …
The U.S. Internet of Things (IoT) market is experiencing rapid growth, driven by accelerating digital transformation across industries and increasing adoption of connected devices. Valued at US$ 142.2 billion in 2024, the market is expected to reach US$ 169.0 billion in 2025 and further expand at an impressive CAGR of 20.1% to reach US$ 609.2 billion by 2032. The United States currently accounts for nearly 20% of the global IoT
Prepackaged Medical Kits & Trays Market Set to Surge to US$47.9 Billion by 2032, Reveals Latest Study
Prepackaged Medical Kits & Trays Market Set to Surge to US$47.9 Billion by 2032, …
The prepackaged medical kits & trays market plays a critical role in enhancing healthcare efficiency, reducing procedure time, and ensuring patient safety. These kits and trays are extensively used across hospitals, clinics, diagnostic centers, and surgical centers, offering ready-to-use medical instruments, consumables, and devices for specific procedures. They streamline workflow, minimize the risk of contamination, and support compliance with stringent regulatory standards. According to the latest study, the global prepackaged
Endodontic Reparative Cement Market Set to Reach US$512.2 Mn by 2032 at 4.7% CAGR
Endodontic Reparative Cement Market Set to Reach US$512.2 Mn by 2032 at 4.7% CAG …
The endodontic reparative cement market plays a crucial role in dental care by enhancing the success of root canal treatments, apexification procedures, and pulp capping. These cements are extensively used by dental professionals for repairing root perforations, sealing retrograde fillings, and promoting periapical healing. They improve biocompatibility, sealing ability, and antimicrobial properties, making them indispensable in modern endodontic procedures. According to the latest study, the global endodontic reparative cement market
Sleep Aids Market to Reach US$41.8 Bn by 2032 with 4.3% CAGR, Says Persistence Market Research
Sleep Aids Market to Reach US$41.8 Bn by 2032 with 4.3% CAGR, Says Persistence M …
The global sleep aids market is poised for substantial growth in the coming years. As of 2025, the market size is projected to be valued at approximately USD 31 billion and is expected to reach USD 41.8 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.3% during the forecast period from 2025 to 2032. This growth is primarily driven by the rising prevalence of sleep disorders, an

All 5 Releases


More Releases for Choroidal

Choroidal Neovascularization Market to Reach USD 18.9 Billion by 2034
Choroidal neovascularization (CNV) refers to the growth of abnormal blood vessels from the choroid into the subretinal space, commonly associated with age-related macular degeneration (AMD), high myopia, ocular trauma, and inflammatory diseases. CNV is a leading cause of vision loss in working-age and elderly populations, making it a critical focus in ophthalmology. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72251 The introduction of anti-VEGF therapies, laser photocoagulation, photodynamic therapy (PDT),
Choroidal Neovascularization Market Size 2024 to 2031.
Market Overview and Report Coverage Choroidal neovascularization, also known as CNV, is a condition characterized by abnormal blood vessel growth in the choroid layer of the eye, which can lead to vision loss if left untreated. The market for treatments of choroidal neovascularization is expected to grow at a CAGR of 7.00% during the forecasted period. The future outlook for the choroidal neovascularization market is optimistic, as advancements in diagnostic
Choroidal Neovascularization Market Size, Share, Industry, Forecast and outlook …
Choroidal Neovascularization Market Choroidal Neovascularization Market Anticipates Significant Growth, Projected to Reach US$ XX Million by 2031 The global Choroidal Neovascularization (CNV) market, valued at US$ XX million in 2023, is poised for substantial expansion, estimated to reach US$ XX million by 2031, with a robust Compound Annual Growth Rate (CAGR) during the forecast period of 2024-2031. Choroidal neovascularization, characterized by the growth of new blood vessels beneath the retina causing visual obstruction,
Choroidal Neovascularization Market to Register Steady Expansion During 2017-202 …
Choroidal neovascularization is a disease that results in the formation of new blood vessels in the brunch membrane of choroid layer of eye. It occurs due to the secretion of excess amount of vascular endothelial growth factor. It can also occur, when a patient suffers with wet macular degeneration. Also, choroidal neovascularization can be caused due to genetic diseases such as optic disc drusen and pseudoxanthoma elasticum. It is also
CNV (Choroidal NeoVascularization) Market Set to Surge Significantly by 2023
Choroid is the part of eye that lies in between the retina (vision sensory area) and the sclera (the outer layer of the eye), this area consist of blood vessels that supply nutrients to the retinal part of our eye. Choroidal NeoVascularization (CNV) is a disease, which is characterized by the formation of new blood vessels that arise either due to the presence of Vascular Endothelial Growth Factors (VGEF) or
Competitive Landscape for CNV Choroidal NeoVascularization Market by Segments - …
The only successful treatment option that is available commercially in the market for CNVs include intravitreal (direct to the eye) injections of anti-VEGF drugs to control the neovascularization and reduce the fluid accumulated. The most common anti-VGEF compounds are Ranibizumab (Trade name: Lucentis), Bevacizumab (Trade name: Avastin) and the novel drug Pegaptanib (Trade name: Macugen). These drugs belong to a class called anti-angiogenic drugs, their primary objective being the inhibition